CAS: 102811-39-2

(E/Z)-Ginkgolic acid C17:2 (Ginkgolic Acid C17:2) is a natural product that can be extracted from Ginkgo biloba and targets human dihydroorotic acid

Ginkgolic acid 17:2 is an alkylphenol derivative, which is a naturally occurring compound extracted from the seeds and leaves of the Ginkgo biloba tree. This compound is characterized by its 17-carbon aliphatic side chain containing two double bonds, contributing to its unique biological properties. Ginkgolic acid exerts its effects primarily through its ability to inhibit certain enzymatic pathways, such as protein tyrosine phosphatases, and disrupt cellular functions by interacting with lipid membranes. This action can lead to various biological effects, including antimicrobial, anticancer, and anti-inflammatory activities. In research contexts, Ginkgolic acid 17:2 is utilized for its potential therapeutic implications and as a tool to study biological systems. Its applications in scientific investigations include exploring its role in modulating cellular signaling pathways and evaluating its potential as a lead compound for drug development, particularly in the fields of oncology and microbiology. However, due to its cytotoxicity, detailed investigations are necessary to understand its pharmacodynamics and optimize its therapeutic index.